Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Abbott Laboratories Dividend Announcement
• Abbott Laboratories announced a quarterly dividend of $0.55 per ordinary share which will be made payable on 2024-11-15. Ex dividend date: 2024-10-15
• Abbott Laboratories annual dividend for 2024 was $2.20
• Abbott Laboratories annual dividend for 2023 was $2.04
• Abbott Laboratories's trailing twelve-month (TTM) dividend yield is 2.35%
• Abbott Laboratories's payout ratio for the trailing twelve months (TTM) is 48.66%
• Abbott Laboratories's dividend growth over the last five years (2018-2023) was 12.74% year
• Abbott Laboratories's dividend growth over the last ten years (2013-2023) was 13.80% year
Abbott Laboratories Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-10-15 | $0.55 | quarterly | 2024-11-15 |
2024-07-15 | $0.55 | quarterly | 2024-08-15 |
2024-04-12 | $0.55 | quarterly | 2024-05-15 |
2024-01-11 | $0.55 | quarterly | 2024-02-15 |
2023-10-12 | $0.51 | quarterly | 2023-11-15 |
2023-07-13 | $0.51 | quarterly | 2023-08-15 |
2023-04-13 | $0.51 | quarterly | 2023-05-15 |
2023-01-12 | $0.51 | quarterly | 2023-02-15 |
2022-10-13 | $0.47 | quarterly | 2022-11-15 |
2022-07-14 | $0.47 | quarterly | 2022-08-15 |
2022-04-13 | $0.47 | quarterly | 2022-05-16 |
2022-01-13 | $0.47 | quarterly | 2022-02-15 |
2021-10-14 | $0.45 | quarterly | 2021-11-15 |
2021-07-14 | $0.45 | quarterly | 2021-08-16 |
2021-04-14 | $0.45 | quarterly | 2021-05-17 |
2021-01-14 | $0.45 | quarterly | 2021-02-16 |
2020-10-14 | $0.36 | quarterly | 2020-11-16 |
2020-07-14 | $0.36 | quarterly | 2020-08-17 |
2020-04-14 | $0.36 | quarterly | 2020-05-15 |
2020-01-14 | $0.36 | quarterly | 2020-02-14 |
2019-10-11 | $0.32 | quarterly | 2019-11-15 |
2019-07-12 | $0.32 | quarterly | 2019-08-15 |
2019-04-12 | $0.32 | quarterly | 2019-05-15 |
2019-01-14 | $0.32 | quarterly | 2019-02-15 |
2018-10-12 | $0.28 | quarterly | 2018-11-15 |
2018-07-12 | $0.28 | quarterly | 2018-08-15 |
2018-04-12 | $0.28 | quarterly | 2018-05-15 |
2018-01-11 | $0.28 | quarterly | 2018-02-15 |
2017-10-12 | $0.27 | quarterly | 2017-11-15 |
2017-07-12 | $0.27 | quarterly | 2017-08-15 |
2017-04-11 | $0.27 | quarterly | 2017-05-15 |
2017-01-11 | $0.27 | quarterly | 2017-02-15 |
2016-10-12 | $0.26 | quarterly | 2016-11-15 |
2016-07-13 | $0.26 | quarterly | 2016-08-15 |
2016-04-13 | $0.26 | quarterly | 2016-05-16 |
2016-01-13 | $0.26 | quarterly | 2016-02-16 |
2015-10-13 | $0.24 | quarterly | 2015-11-15 |
2015-07-13 | $0.24 | quarterly | 2015-08-15 |
2015-04-13 | $0.24 | quarterly | 2015-05-15 |
2015-01-13 | $0.24 | quarterly | 2015-02-13 |
2014-10-10 | $0.22 | quarterly | 2014-11-15 |
2014-07-11 | $0.22 | quarterly | 2014-08-15 |
2014-04-11 | $0.22 | quarterly | 2014-05-15 |
2014-01-13 | $0.22 | quarterly | 2014-02-15 |
2013-10-10 | $0.14 | quarterly | 2013-11-15 |
2013-07-11 | $0.14 | quarterly | 2013-08-15 |
2013-04-11 | $0.14 | quarterly | 2013-05-15 |
2013-01-11 | $0.14 | quarterly | 2013-02-15 |
Abbott Laboratories Dividend per year
Abbott Laboratories Dividend growth
Abbott Laboratories Dividend Yield
Abbott Laboratories current trailing twelve-month (TTM) dividend yield is 2.35%. Interested in purchasing Abbott Laboratories stock? Use our calculator to estimate your expected dividend yield:
Abbott Laboratories Financial Ratios
Abbott Laboratories Dividend FAQ
Other factors to consider when evaluating Abbott Laboratories as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Abbott Laboratories stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Abbott Laboratories's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Abbott Laboratories publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Abbott Laboratories distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Abbott Laboratories are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Abbott Laboratories sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Abbott Laboratories distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Abbott Laboratories declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Abbott Laboratories's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Abbott Laboratories's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.